ChartRow logo
ChartRow
Investing Charts
MRK
Merck & Co. Inc.Stock · HealthcareDow Jones 1.4% · S&P 500 0.5%
$131.09+$0.61 (+0.47%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

MRKMerck & Co. Inc. stock price, chart and key statistics

Key stats

Price data

Price
$131.09
Change YTD
+23.15%
Next earnings
Aug 4, 2026 · Before open
Market cap
323.8B
Enterprise value
365.1B
Shares outstanding
2.5B
52W low
$76.66
52W high
$131.74
From 52W high
-0.49%
From 52W low
+71.00%
52W range
99%
Beta
0.20

Volume

Rel volume
0.79×
30D volume
10.6M
30D $ vol
1.3B

Fundamentals

Sales (ttm)
65.8B
Sales/share
$26.63
EPS (ttm)
$3.61
FCF (ttm)
14.1B
FCF/share
$5.71
Book value/share
$18.58
Net margin
13.59%
ROE
19.48%
ROA
6.94%
Debt / equity
1.02×
Current ratio
1.30

Growth (CAGR, ttm) · 10Y

Sales
n/a
Net income
+6.83%
FCF
+2.46%
Shares
-1.13%

Per-share growth (CAGR, ttm) · 10Y

EPS
+8.15%
Sales/share
n/a
FCF/share
+3.64%
Book value/share
+1.62%
Dividend/share
+6.20%
Price
+8.85%
Total return
+12.13%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
36.2×
Fwd P/E
13.2×
P/S (ttm)
4.9×
P/B (mrq)
7.1×
P/FCF (ttm)
22.9×
EV/Sales (ttm)
5.6×
FCF yield (ttm)
4.36%
Dividend yield (fwd)
2.59%
Dividend/share (fwd)
$3.40
Buyback yield (ttm)
1.48%
Shareholder yield (ttm)
4.02%

Vs own 10Y history

P/E
73rd
P/S
86th
P/B
76th
P/FCF
52nd

Bar = where today's multiple sits in MRK's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.47%
1W
+2.82%
1M
+8.70%
3M
+14.37%
YTD
+23.15%
1Y
+56.10%
5Y
+68.02%

Financial statements

Open full MRK financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B
GILD
Gilead Sciences Inc.
Biotech$129+3.32%976.5M

Merck & Co. Inc. (MRK) trades at $131.09 with a live price and an interactive chart covering 56+ years of daily price history, plus key valuation metrics. ChartRow also publishes MRK's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MRK financial statements →